Pages that link to "Q43174219"
Jump to navigation
Jump to search
The following pages link to 2009 influenza A(H1N1) seroconversion rates and risk factors among distinct adult cohorts in Singapore. (Q43174219):
Displaying 50 items.
- Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study (Q28269717) (← links)
- Epidemiological characteristics and underlying risk factors for mortality during the autumn 2009 pandemic wave in Mexico (Q28729170) (← links)
- Incidence of H1N1 2009 virus infection through the analysis of paired plasma specimens among blood donors, France (Q28730980) (← links)
- Prevalence of 2009 pandemic influenza A (H1N1) virus antibodies, Tampa Bay Florida--November-December, 2009 (Q28741061) (← links)
- A clinical diagnostic model for predicting influenza among young adult military personnel with febrile respiratory illness in Singapore (Q28742295) (← links)
- Seroprevalence of pandemic influenza H1N1 in Ontario from January 2009-May 2010 (Q28742786) (← links)
- Effectiveness of pandemic H1N1-2009 vaccination in reducing laboratory confirmed influenza infections among military recruits in tropical Singapore (Q28743357) (← links)
- Estimating infection attack rates and severity in real time during an influenza pandemic: analysis of serial cross-sectional serologic surveillance data (Q30000940) (← links)
- Estimating age-specific cumulative incidence for the 2009 influenza pandemic: a meta-analysis of A(H1N1)pdm09 serological studies from 19 countries (Q30223476) (← links)
- Two years after pandemic influenza A/2009/H1N1: what have we learned? (Q30224656) (← links)
- Prevalence of antibodies against seasonal influenza A and B viruses during the 2009-2010 and 2010-2011 influenza seasons in residents of Pittsburgh, PA, USA (Q30224919) (← links)
- Epidemiological characteristics of 2009 (H1N1) pandemic influenza based on paired sera from a longitudinal community cohort study. (Q30226505) (← links)
- Seroprevalence to Influenza A(H1N1) 2009 Virus—Where Are We? (Q30226546) (← links)
- Pandemic response lessons from influenza H1N1 2009 in Asia (Q30226556) (← links)
- Factors influencing infection by pandemic influenza A(H1N1)pdm09 over three epidemic waves in Singapore. (Q30351890) (← links)
- Epidemiological characteristics of the influenza A(H1N1) 2009 pandemic in the Western Pacific Region. (Q30352545) (← links)
- Pandemic influenza A/H1N1pdm in Italy: age, risk and population susceptibility. (Q30354383) (← links)
- Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study. (Q30361230) (← links)
- Rate of decline of antibody titers to pandemic influenza A (H1N1-2009) by hemagglutination inhibition and virus microneutralization assays in a cohort of seroconverting adults in Singapore (Q30365168) (← links)
- High rate of A(H1N1)pdm09 infections among rural Thai villagers, 2009-2010. (Q30366422) (← links)
- Hemagglutination inhibiting antibodies and protection against seasonal and pandemic influenza infection (Q30366832) (← links)
- Risk factors of pandemic influenza A/H1N1 in a prospective household cohort in the general population: results from the CoPanFlu-France cohort. (Q30369574) (← links)
- Seasonal influenza vaccine and protection against pandemic (H1N1) 2009-associated illness among US military personnel (Q30389669) (← links)
- Seroconversion and asymptomatic infections during oseltamivir prophylaxis against Influenza A H1N1 2009. (Q30390209) (← links)
- The Occupational Risk of Influenza A (H1N1) Infection among Healthcare Personnel during the 2009 Pandemic: A Systematic Review and Meta-Analysis of Observational Studies (Q30392438) (← links)
- Efficacy of a trivalent influenza vaccine against seasonal strains and against 2009 pandemic H1N1: A randomized, placebo-controlled trial. (Q30392551) (← links)
- Inactivated trivalent seasonal influenza vaccine induces limited cross-reactive neutralizing antibody responses against 2009 pandemic and 1934 PR8 H1N1 strains. (Q30392786) (← links)
- Seroepidemiology of pandemic influenza A (H1N1) 2009 virus infections in Pune, India (Q30392935) (← links)
- Influenza A (H1N1) 2009 antibodies in residents of New South Wales, Australia, after the first pandemic wave in the 2009 southern hemisphere winter (Q30393480) (← links)
- Serological survey of 2009 H1N1 influenza in residents of Beijing, China (Q30393913) (← links)
- Risk factors for pandemic (H1N1) 2009 virus seroconversion among hospital staff, Singapore (Q30394173) (← links)
- Reflections on pandemic (H1N1) 2009 and the international response (Q30395014) (← links)
- Risk factors and immunity in a nationally representative population following the 2009 influenza A(H1N1) pandemic (Q30395289) (← links)
- Pandemic (H1N1) 2009 Influenza Virus Seroconversion Rates in HIV-Infected Individuals (Q30396368) (← links)
- Limited novel influenza A (H1N1) 09 infection in travelling high-school tour group (Q30397110) (← links)
- Assortativity and the Probability of Epidemic Extinction: A Case Study of Pandemic Influenza A (H1N1-2009) (Q30398574) (← links)
- Serological analysis of human pandemic influenza (H1N1) in Thailand (Q30398905) (← links)
- Serological evidence of subclinical transmission of the 2009 pandemic H1N1 influenza virus outside of Mexico (Q30398986) (← links)
- Retrospective investigation of an influenza A/H1N1pdm outbreak in an Italian military ship cruising in the Mediterranean Sea, May-September 2009 (Q30399178) (← links)
- Rethinking thresholds for serological evidence of influenza virus infection (Q30399931) (← links)
- Immune response to pandemic H1N1 2009 influenza a vaccination in pediatric liver transplant recipients (Q30400161) (← links)
- Did modeling overestimate the transmission potential of pandemic (H1N1-2009)? Sample size estimation for post-epidemic seroepidemiological studies (Q30401351) (← links)
- Sensitivity and Specificity of Serologic Assays for Detection of Human Infection with 2009 Pandemic H1N1 Virus in U.S. Populations (Q30401611) (← links)
- Seroprevalence of antibody to pandemic influenza A (H1N1) 2009 among healthcare workers after the first wave in Hong Kong (Q30401952) (← links)
- The seroprevalence of pandemic influenza H1N1 (2009) virus in China (Q30402225) (← links)
- How common was 2009 pandemic influenza A H1N1? (Q30403174) (← links)
- Serological survey of antibodies to influenza A viruses in a group of people without a history of influenza vaccination (Q30404694) (← links)
- Pandemic (H1N1) 2009 risk for frontline health care workers. (Q30404711) (← links)
- Seroepidemiological study of pandemic influenza H1N1 following the 2009-2010 wave in Greece (Q30404938) (← links)
- Clinical and nonclinical health care workers faced a similar risk of acquiring 2009 pandemic H1N1 infection (Q30404968) (← links)